You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AMLX Sale Disclosure
Klee Justin B. · SEC Form 4 · Filed Nov 12, 2026
Sale
Calculated transaction value
$1.1M
Klee Justin B. Co-chief Executive Officer
AMLX
Transaction date
Nov 9, 2026
Public filing date
Nov 12, 2026
Filing lag
Filed 3 days later
AMLX daily price context
Close on/before transaction
$30.21
Nov 9, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 37,483 shares @ $29.39
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-458246
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$2.98M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. AMLX Current | Sale | Nov 9, 2026 | $1.1M |
| Amylyx Pharmaceuticals, Inc. AMLX | Sale | Nov 9, 2026 | $1.88M |